Correlation Between Chung Hsin and Medigen Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chung Hsin and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chung Hsin and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chung Hsin Electric Machinery and Medigen Biotechnology, you can compare the effects of market volatilities on Chung Hsin and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chung Hsin with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chung Hsin and Medigen Biotechnology.

Diversification Opportunities for Chung Hsin and Medigen Biotechnology

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Chung and Medigen is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Chung Hsin Electric Machinery and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and Chung Hsin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chung Hsin Electric Machinery are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of Chung Hsin i.e., Chung Hsin and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between Chung Hsin and Medigen Biotechnology

Assuming the 90 days trading horizon Chung Hsin Electric Machinery is expected to generate 1.39 times more return on investment than Medigen Biotechnology. However, Chung Hsin is 1.39 times more volatile than Medigen Biotechnology. It trades about -0.01 of its potential returns per unit of risk. Medigen Biotechnology is currently generating about -0.13 per unit of risk. If you would invest  15,950  in Chung Hsin Electric Machinery on September 1, 2024 and sell it today you would lose (150.00) from holding Chung Hsin Electric Machinery or give up 0.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Chung Hsin Electric Machinery  vs.  Medigen Biotechnology

 Performance 
       Timeline  
Chung Hsin Electric 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chung Hsin Electric Machinery has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Medigen Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Chung Hsin and Medigen Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chung Hsin and Medigen Biotechnology

The main advantage of trading using opposite Chung Hsin and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chung Hsin position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.
The idea behind Chung Hsin Electric Machinery and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity